X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-15 | IRON | Savage William Jacob | Chief Medical Officer | S - Sale+OE | $59.64 | -9,158 | 40,405 | -18% | -$546,153 | |||||
| DM | 2024-11-01 | IRON | White William Richard | Dir | S - Sale+OE | $58.27 | -7,337 | 0 | -100% | -$427,526 | |||||
| D | 2024-10-01 | IRON | White William Richard | Dir | S - Sale+OE | $51.31 | -201 | 0 | -100% | -$10,312 | |||||
2024-09-16 | IRON | Savage William Jacob | Chief Medical Officer | S - Sale | $47.41 | -1,500 | 40,405 | -4% | -$71,115 | ||||||
| D | 2024-09-03 | IRON | White William Richard | Dir | S - Sale+OE | $49.65 | -1,957 | 0 | -100% | -$97,158 | |||||
2024-09-03 | IRON | Savage William Jacob | Chief Medical Officer | S - Sale | $50.59 | -1,500 | 41,905 | -3% | -$75,885 | ||||||
| D | 2024-08-01 | IRON | White William Richard | Dir | S - Sale+OE | $43.44 | -201 | 0 | -100% | -$8,731 | |||||
| D | 2024-07-01 | IRON | White William Richard | Dir | S - Sale+OE | $46.04 | -201 | 0 | -100% | -$9,253 | |||||
2024-06-17 | IRON | Bitterman Kevin | Dir | P - Purchase | $36.00 | +222,223 | 1,149,052 | +24% | +$8,000,028 | ||||||
2024-06-17 | IRON | Ashiya Mona | Dir | P - Purchase | $36.00 | +83,334 | 235,391 | +55% | +$3,000,024 | ||||||
2024-06-17 | IRON | Orbimed Advisors LLC | Dir | P - Purchase | $36.00 | +83,334 | 235,391 | +55% | +$3,000,024 | ||||||
| D | 2024-06-03 | IRON | White William Richard | Dir | S - Sale+OE | $36.08 | -1,957 | 0 | -100% | -$70,608 | |||||
| D | 2024-05-01 | IRON | White William Richard | Dir | S - Sale+OE | $28.63 | -201 | 0 | -100% | -$5,755 | |||||
| D | 2024-04-11 | IRON | White William Richard | Dir | S - Sale+OE | $31.80 | -2,560 | 0 | -100% | -$81,407 | |||||
2024-03-05 | IRON | Bitterman Kevin | Dir | S - Sale | $73.50 | -26,157 | 926,829 | -3% | -$1,922,540 | ||||||
2024-01-23 | IRON | Bitterman Kevin | Dir | S - Sale | $67.65 | -102,500 | 249,326 | -29% | -$6,934,125 | ||||||
2024-01-23 | IRON | Atlas Venture Fund X, L.P. | 10% | S - Sale | $67.65 | -150,000 | 1,600,512 | -9% | -$10,147,500 | ||||||
2024-01-10 | IRON | Bitterman Kevin | Dir | S - Sale | $64.00 | -20,000 | 1,055,486 | -2% | -$1,280,000 | ||||||
2024-01-10 | IRON | Atlas Venture Fund X, L.P. | 10% | S - Sale | $64.00 | -50,000 | 2,235,846 | -2% | -$3,200,000 | ||||||
| D | 2023-12-18 | IRON | Orbimed Advisors LLC | Dir | S - Sale+OE | $59.24 | -1,724 | 1,702,237 | 0% | -$102,130 | |||||
| D | 2023-12-18 | IRON | Ashiya Mona | Dir | S - Sale+OE | $59.24 | -1,724 | 1,702,237 | 0% | -$102,130 | |||||
2023-12-14 | IRON | Ashiya Mona | Dir | S - Sale | $56.75 | -433,200 | 224,405 | -66% | -$24,584,100 | ||||||
2023-12-14 | IRON | Orbimed Advisors LLC | Dir | S - Sale | $56.75 | -433,200 | 224,405 | -66% | -$24,584,100 | ||||||
| M | 2023-12-12 | IRON | Bitterman Kevin | Dir | S - Sale | $61.45 | -76,064 | 1,075,486 | -7% | -$4,673,759 | |||||
| M | 2023-12-12 | IRON | Atlas Venture Fund X, L.P. | 10% | S - Sale | $61.45 | -190,163 | 2,285,846 | -8% | -$11,684,586 | |||||
| M | 2023-12-12 | IRON | Orbimed Advisors LLC | Dir | S - Sale | $58.88 | -134,200 | 727,807 | -16% | -$7,902,266 | |||||
| M | 2023-12-12 | IRON | Ashiya Mona | Dir | S - Sale | $58.88 | -134,200 | 727,807 | -16% | -$7,902,266 | |||||
| D | 2023-12-12 | IRON | White William Richard | Dir | S - Sale+OE | $63.21 | -33,511 | 0 | -100% | -$2,118,239 | |||||
| D | 2023-12-12 | IRON | Bryce Joanne | CFO | S - Sale+OE | $65.22 | -2,500 | 2,500 | -50% | -$163,062 | |||||
| D | 2023-12-05 | IRON | Bryce Joanne | CFO | S - Sale+OE | $56.00 | -2,541 | 2,500 | -50% | -$142,299 | |||||
| D | 2023-11-22 | IRON | Khara Rahul | GC | S - Sale+OE | $51.73 | -10,000 | 0 | -100% | -$517,333 | |||||
| D | 2023-11-14 | IRON | Khara Rahul | GC | S - Sale+OE | $50.61 | -4,900 | 0 | -100% | -$248,012 | |||||
| D | 2023-11-03 | IRON | Khara Rahul | GC | S - Sale+OE | $50.00 | -100 | 0 | -100% | -$5,000 | |||||
| M | 2023-09-14 | IRON | Atlas Venture Fund X, L.P. | 10% | S - Sale | $53.13 | -357,449 | 1,593,785 | -18% | -$18,991,727 | |||||
| D | 2023-09-01 | IRON | Bryce Joanne | CFO | S - Sale+OE | $52.99 | -1,000 | 1,260 | -44% | -$52,990 | |||||
2023-08-15 | IRON | Bitterman Kevin | Dir | S - Sale | $52.40 | -72,931 | 1,151,550 | -6% | -$3,821,584 | ||||||
| M | 2023-08-14 | IRON | Atlas Venture Fund X, L.P. | 10% | S - Sale | $52.49 | -359,000 | 2,833,458 | -11% | -$18,845,200 | |||||
2023-08-15 | IRON | Savage William Jacob | Chief Medical Officer | S - Sale | $52.95 | -7,672 | 0 | -100% | -$406,235 | ||||||
2023-08-09 | IRON | Savage William Jacob | Chief Medical Officer | S - Sale | $49.83 | -8,269 | 7,672 | -52% | -$412,064 | ||||||
| D | 2023-08-01 | IRON | Bryce Joanne | CFO | S - Sale+OE | $49.91 | -4,521 | 1,260 | -78% | -$225,633 | |||||
| M | 2023-06-28 | IRON | Macdonald Brian Richard | Chief Innovation Officer | S - Sale | $47.02 | -15,124 | 15,564 | -49% | -$711,140 | |||||
| D | 2023-06-28 | IRON | Bryce Joanne | CFO | S - Sale+OE | $49.95 | -10,072 | 1,260 | -89% | -$503,114 | |||||
2023-06-28 | IRON | Savage William Jacob | Chief Medical Officer | S - Sale | $49.98 | -4,384 | 15,941 | -22% | -$219,114 | ||||||
2023-06-28 | IRON | Novo Holdings A/s | 10% | S - Sale | $46.10 | -1,250,000 | 1,090,772 | -53% | -$57,625,000 | ||||||
2023-02-15 | IRON | Ashiya Mona | Dir, 10% | P - Purchase | $23.00 | +108,696 | 299,205 | +57% | +$2,500,008 | ||||||
2023-02-15 | IRON | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $23.00 | +108,696 | 299,205 | +57% | +$2,500,008 | ||||||
2023-02-15 | IRON | Ai Dmi LLC | 10% | P - Purchase | $23.00 | +434,783 | 3,141,759 | +16% | +$10,000,009 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |